Pharmacovigilance in resource-limited countries

S Olsson, SN Pal, A Dodoo - Expert review of clinical …, 2015 - Taylor & Francis
In the past 20 years, many low- and middle-income countries have created national
pharmacovigilance (PV) systems and joined the WHO’s global PV network. However, very few of …

Specific features of medicines safety and pharmacovigilance in Africa

AO Isah, SN Pal, S Olsson, A Dodoo… - … advances in drug …, 2012 - journals.sagepub.com
The thalidomide tragedy in the late 1950s and early 1960s served as a wakeup call and
raised questions about the safety of medicinal products. The developed countries rose to the …

[HTML][HTML] WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems

SN Pal, C Duncombe, D Falzon, S Olsson - Drug safety, 2013 - Springer
Globally, national pharmacovigilance systems rely on spontaneous reporting in which suspected
adverse drug reactions (ADRs) are reported to a national coordinating centre by health …

Pharmacovigilance activities in 55 low-and middle-income countries: a questionnaire-based analysis

S Olsson, SN Pal, A Stergachis, M Couper - Drug safety, 2010 - Springer
Background: The WHO Programme for International Drug Monitoring aims to develop a
comprehensive global pharmacovigilance strategy that responds to the healthcare needs of low- …

[HTML][HTML] Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of …

HH Ampadu, J Hoekman, ML de Bruin, SN Pal… - Drug safety, 2016 - Springer
Introduction Following the start of the World Health Organization (WHO) Programme for
International Drug Monitoring (PIDM) by 10 member countries in 1968, it took another 24 years …

Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections

ME Ragozzino, SN Pal, K Unick… - Journal of …, 1998 - Soc Neuroscience
Recent evidence indicates that systemic glucose treatment enhances memory while
producing a corresponding increase in hippocampal acetylcholine (ACh) output. The present …

[HTML][HTML] The monitoring medicines project: a multinational pharmacovigilance and public health project

SN Pal, S Olsson, EG Brown - Drug safety, 2015 - Springer
… This article is part of a theme issue co-edited by Shanthi Pal, Sten Olsson and Elliot
Brown. No external funding was used to support the publication of this theme issue. …

[PDF][PDF] Patterns of prescriptions and drug use in two tertiary hospitals in Delhi

…, PS Pal, SK Jain, SP Malhotra, A Gupta, SN Pal - Indian Journal of …, 2000 - ijpp.com
The study was carried out to assess prescribing trends in outpatients at Dr. RP Centre for
Ophthalmic Sciences(RPC) and other OPD's of All India Institute of Medical Sciences (AIIMS) …

Competition between memory systems: acetylcholine release in the hippocampus correlates negatively with good performance on an amygdala-dependent task

CK McIntyre, SN Pal, LK Marriott… - Journal of …, 2002 - Soc Neuroscience
Lesions of the amygdala impair acquisition of a food conditioned place preference (CPP)
task. In contrast, lesions of the fornix facilitate acquisition on this task, showing that an intact …

[HTML][HTML] Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum

…, M Lindquist, J McEwen, Y Moride, S Olsson, SN Pal… - Drug safety, 2014 - Springer
The importance of pharmacovigilance (PV) for safe medicines and their safe use has increasingly
been recognised during the last few years [1]. PV has been subject of intense research …